Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should elderly heart failure patients be treated with β-blockade therapy?

Nature Clinical Practice Cardiovascular Medicine volume 2, pages 14–15 (2005)Cite this article

boxed-textDeedwania PC et al. for the MERIT-HF Study Group (2004) Efficacy, safety and tolerability of β-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur Heart J 25: 1300–1309

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Remme WJ and Swedberg K (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22: 1527–1560

    Article  CAS  Google Scholar 

  2. The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 1429–1435

  3. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293–302

  4. Erdmann E et al. (2001) Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. Eur J Heart Fail 3: 469–479

    Article  CAS  Google Scholar 

  5. Packer M et al. (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344: 1651–1658

    Article  CAS  Google Scholar 

  6. Cleland JGF et al. (2004) Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial. Eur J Heart Fail 6: 787–791

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. the Göteborg University and Senior Physician in the Department of Medicine, Cardiovascular Institute, Sahlgrenska University Hospital/Östra, Göteborg, Sweden

    Karl Swedberg

Authors
  1. Karl Swedberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karl Swedberg.

Ethics declarations

Competing interests

K Swedberg has received research support and honoraria from Astrazeneca, Roche, Glaxo SmithKline and other major cardiovascular pharmaceutical companies.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Swedberg, K. Should elderly heart failure patients be treated with β-blockade therapy?. Nat Rev Cardiol 2, 14–15 (2005). https://doi.org/10.1038/ncpcardio0077

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0077

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing